Jeito Capital co-leads €164.5 million ($181.4 million) oversubscribed Series D financing in Alentis Therapeutics to advance clinical development of Anti-Claudin-1 ADCs in solid tumors

Jeito Capital co-leads €164.5 million1 oversubscribed Series D financing in Alentis Therapeutics to advance clinical development ofAnti-Claudin-1 ADCs in solid tumors Building on its co-lead investments in Alentis Therapeutics’ Series B and Series C rounds, Jeito’s renewed commitment demonstrates its strategy of supporting promising portfolio

Ethylene Vinyl Acetate Market to Reach USD 19.2 Billion by 2032 Driven by Rising Demand for Sustainable Packaging Solutions | Report by SNS Insider

The rise in demand for Ethylene Vinyl Acetate-based beauty and healthcare products continues to accelerate due to advancements in scientific research and increasing consumer awareness about Ethylene Vinyl Acetate’s benefits. Austin, Nov. 12, 2024 — What is the growth of the Ethylene Vinyl Acetate market? The Ethylene Vinyl